NMDA Receptor Antagonist Attenuates Bleomycin-Induced Acute Lung Injury.
Where this comes from
- Record sourced from PubMed, PMID 25942563.
- Also identified by DOI 10.1371/journal.pone.0125873 and PMC identifier 4420245.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
BACKGROUND: Glutamate is a major neurotransmitter in the central nervous system (CNS). Large amount of glutamate can overstimulate N-methyl-D-aspartate receptor (NMDAR), causing neuronal injury and death. Recently, NMDAR has been reported to be found in the lungs. The aim of this study is to examine the effects of memantine, a NMDAR channel blocker, on bleomycin-induced lung injury mice. METHODS: C57BL/6 mice were intratracheally injected with bleomycin (BLM) to induce lung injury. Mice were randomized to receive saline, memantine (Me), BLM, BLM plus Me. Lungs and BALF were harvested on day 3 or 7 for further evaluation. RESULTS: BLM caused leukocyte infiltration, pulmonary edema and increase in cytokines, and imposed significant oxidative stress (MDA as a marker) in lungs. Memantine significantly mitigated the oxidative stress, lung inflammatory response and acute lung injury caused by BLM. Moreover, activation of NMDAR enhances CD11b expression on neutrophils. CONCLUSIONS: Memantine mitigates oxidative stress, lung inflammatory response and acute lung injury in BLM challenged mice.
Medical subject headings
- Acute Lung Injury
- Antibiotics, Antineoplastic
- Bleomycin
- Receptors, N-Methyl-D-Aspartate